Ludger Tebartz van Elst Selected Research

Hashimoto's encephalitis

1/2023	Steroid-responsive encephalopathy associated with autoimmune thyroiditis presenting as cortisone sensible psychosis with reversible leukoencephalopathy.
5/2019	[Autoantibody-associated schizophreniform psychoses: clinical symptomatology].
1/2017	Steroid-Responsive Chronic Schizophreniform Syndrome in the Context of Mildly Increased Antithyroid Peroxidase Antibodies.
1/2017	Intrathecal Thyroid Autoantibody Synthesis in a Subgroup of Patients With Schizophreniform Syndromes.
1/2017	Plasmapheresis Responsive Rapid Onset Dementia with Predominantly Frontal Dysfunction in the Context of Hashimoto's Encephalopathy.
1/2016	Steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT) presenting as major depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ludger Tebartz van Elst Research Topics

Disease

16	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2023 - 08/2002
13	Psychotic Disorders (Schizoaffective Disorder) 01/2023 - 05/2015
8	Schizophrenia (Dementia Praecox) 01/2023 - 02/2008
7	Autism Spectrum Disorder 11/2023 - 01/2017
6	Mental Disorders (Mental Disorder) 01/2024 - 06/2017
6	Hashimoto's encephalitis 01/2023 - 01/2016
6	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2023 - 06/2017
5	Autoimmune Diseases of the Nervous System 01/2023 - 05/2019
5	Seizures (Absence Seizure) 06/2020 - 01/2016
4	Encephalitis (Encephalitis, Rasmussen) 01/2022 - 01/2019
4	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 01/2021 - 01/2016
3	Neuroinflammatory Diseases 01/2024 - 12/2020
3	Leukocytosis (Pleocytosis) 01/2023 - 07/2016
3	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 01/2023 - 06/2020
3	Depressive Disorder (Melancholia) 06/2021 - 07/2020
3	Brain Diseases (Brain Disorder) 07/2020 - 05/2019
2	Sarcoidosis (Schaumann Disease) 01/2024 - 12/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 11/2023
2	Infections 01/2023 - 06/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2020
2	Tauopathies 01/2023 - 06/2020
2	Dementia (Dementias) 01/2022 - 01/2017
2	Mood Disorders (Mood Disorder) 01/2022 - 01/2021
2	Autistic Disorder (Autism) 01/2022 - 01/2017
2	Movement Disorders (Movement Disorder) 06/2020 - 01/2019
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 06/2020 - 01/2015
2	Catatonia 01/2020 - 01/2019
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 01/2020 - 01/2019
2	Hallucinations (Hallucination) 01/2019 - 01/2017
1	Leukoencephalopathies 01/2023
1	Frontotemporal Dementia (Semantic Dementia) 01/2023
1	Hypersensitivity (Allergy) 11/2022
1	Meningoencephalitis 11/2022
1	Neurodevelopmental Disorders 11/2022
1	Confusion (Bewilderment) 02/2022
1	Encephalomyelitis (Myeloencephalitis) 02/2022
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2022
1	Paranoid Schizophrenia (Delusional Disorder) 01/2022
1	Huntington Disease (Huntington's Disease) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Avitaminosis (Vitamin Deficiency) 09/2020
1	Hashimoto Disease (Thyroiditis, Hashimoto) 07/2020
1	Myoclonus (Nocturnal Myoclonus) 06/2020
1	Disease Progression 06/2020
1	Parkinsonian Disorders (Parkinsonism) 06/2020
1	Progressive Encephalomyelitis with Rigidity 06/2020

Drug/Important Bio-Agent (IBA)

18	AntibodiesIBA 01/2023 - 05/2015
16	AutoantibodiesIBA 01/2023 - 01/2015
10	Methylphenidate (Ritalin)FDA LinkGeneric 01/2023 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2018
5	Retinaldehyde (Retinal)IBA 12/2022 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2020
4	Immunoglobulin G (IgG)IBA 01/2023 - 05/2018
4	Oligoclonal BandsIBA 01/2023 - 07/2016
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 01/2019
4	N-Methylaspartate (NMDA)IBA 01/2023 - 01/2019
4	Glutamic Acid (Glutamate)FDA Link 01/2022 - 02/2008
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2023 - 01/2019
3	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2023 - 09/2020
3	CytokinesIBA 01/2023 - 10/2020
3	Antinuclear AntibodiesIBA 01/2023 - 01/2017
3	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 01/2017
3	AlbuminsIBA 06/2021 - 06/2020
3	SteroidsIBA 05/2019 - 01/2016
2	NeopterinIBA 01/2024 - 12/2022
2	AntigensIBA 01/2023 - 05/2015
2	EnzymesIBA 01/2023 - 07/2020
2	Interleukin-8 (Interleukin 8)IBA 01/2021 - 10/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2019
2	Inositol (Myoinositol)IBA 01/2019 - 03/2011
1	Serotonin (5 Hydroxytryptamine)IBA 01/2024
1	Fatty Acids (Saturated Fatty Acids)IBA 11/2023
1	Pyruvic Acid (Pyruvate)IBA 11/2023
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2023
1	Antiphospholipid AntibodiesIBA 01/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Cortisone FDA Link 01/2023
1	Rituximab (Mabthera)FDA Link 01/2023
1	Semaphorin-3AIBA 01/2023
1	Ma2 antigenIBA 01/2023
1	Serum AlbuminIBA 12/2022
1	anti-GFAP autoantibodiesIBA 11/2022
1	Immunomodulating AgentsIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	gamma-Aminobutyric Acid (GABA)IBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 06/2021
1	Cell Adhesion MoleculesIBA 06/2021
1	anti-thyroid autoantibodiesIBA 01/2021
1	ChemokinesIBA 10/2020
1	Complement System Proteins (Complement)IBA 09/2020
1	VitaminsIBA 09/2020
1	Thyroid HormonesIBA 09/2020
1	ImmunosorbentsIBA 07/2020
1	Iodide Peroxidase (Deiodinase)IBA 07/2020
1	anti-thyroglobulinIBA 07/2020
1	Glycine Receptors (Glycine Receptor)IBA 06/2020

Therapy/Procedure

10	Therapeutics 12/2023 - 08/2002
2	Plasmapheresis 01/2023 - 01/2017
2	Combined Modality Therapy 01/2022 - 01/2019
1	Immunotherapy 12/2022